The effectiveness of piperlongumine in neurodegenerative diseases is due to its ability to inhibit or reduce the synthesis of prostaglandins E2, nitric oxide, cyclooxygenases-2, nuclear factor kappa B, interleukin-6, and tumor necrosis factor-alpha 9 [121,122]. Here, TNF is linked to neurodegenerative disease.